ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.667
-0.20%
Brent Oil
81.965
0.00%
Bitcoin
69,114.24
-0.22%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. POINT Biopharma Global Inc (PNT)

  7. POINT Biopharma Global Inc (PNT) Noticias

PNT

POINT Biopharma Global (PNT)

POINT Biopharma Global Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PNT
FechaHoraFuenteTítuloSímboloCompañía
08/01/202406:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:PNTPOINT Biopharma Global Inc
02/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PNTPOINT Biopharma Global Inc
27/12/202316:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PNTPOINT Biopharma Global Inc
27/12/202308:44Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PNTPOINT Biopharma Global Inc
27/12/202308:42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PNTPOINT Biopharma Global Inc
27/12/202307:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PNTPOINT Biopharma Global Inc
27/12/202307:31PR Newswire (US)Lilly Completes Acquisition of POINT BiopharmaNASDAQ:PNTPOINT Biopharma Global Inc
18/12/202307:14Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:PNTPOINT Biopharma Global Inc
18/12/202306:30GlobeNewswire Inc.Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate CancerNASDAQ:PNTPOINT Biopharma Global Inc
18/12/202305:45PR Newswire (US)Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023NASDAQ:PNTPOINT Biopharma Global Inc
05/12/202305:25IH Market NewsMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio Plans Major Layoffs, and MoreNASDAQ:PNTPOINT Biopharma Global Inc
04/12/202305:45PR Newswire (US)Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023NASDAQ:PNTPOINT Biopharma Global Inc
17/11/202305:45PR Newswire (US)Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023NASDAQ:PNTPOINT Biopharma Global Inc
14/11/202315:33PR Newswire (US)Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT BiopharmaNASDAQ:PNTPOINT Biopharma Global Inc
13/11/202306:30GlobeNewswire Inc.POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business HighlightsNASDAQ:PNTPOINT Biopharma Global Inc
13/11/202306:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PNTPOINT Biopharma Global Inc
08/11/202315:56PR Newswire (US)Lilly Announces Extension of Tender Offer to Acquire POINT BiopharmaNASDAQ:PNTPOINT Biopharma Global Inc
13/10/202306:11Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:PNTPOINT Biopharma Global Inc
03/10/202316:24Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:PNTPOINT Biopharma Global Inc
03/10/202309:03IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNASDAQ:PNTPOINT Biopharma Global Inc
03/10/202305:45PR Newswire (US)Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand TherapiesNASDAQ:PNTPOINT Biopharma Global Inc
18/09/202307:00GlobeNewswire Inc.POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted RadioligandsNASDAQ:PNTPOINT Biopharma Global Inc
14/08/202309:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PNTPOINT Biopharma Global Inc
14/08/202306:30GlobeNewswire Inc.POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business HighlightsNASDAQ:PNTPOINT Biopharma Global Inc
31/07/202308:00GlobeNewswire Inc.ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177NASDAQ:PNTPOINT Biopharma Global Inc
26/06/202306:45GlobeNewswire Inc.POINT Biopharma and AdvanCell to Collaborate in the Development of Lead-212-Labeled RadioligandsNASDAQ:PNTPOINT Biopharma Global Inc
26/06/202306:30GlobeNewswire Inc.POINT Biopharma Expands Its Research with Next-Generation Isotopes, Publishing New Preclinical Data at SNMMI’s Annual CongressNASDAQ:PNTPOINT Biopharma Global Inc
14/06/202317:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PNTPOINT Biopharma Global Inc
14/06/202317:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PNTPOINT Biopharma Global Inc
12/06/202307:00GlobeNewswire Inc.POINT Biopharma Announces Appointment of Dr. Bridget Martell to its Board of DirectorsNASDAQ:PNTPOINT Biopharma Global Inc
 Showing the most relevant articles for your search:NASDAQ:PNT

Su Consulta Reciente

USOTC
BRPHF
Galaxy Digital (PK)
BOV
PAGS34Q
PagSeguro Digital
LSE
GXLE
Spdr $ Energy
NASDAQ
KBLM
KBL Merger Corporation IV
NASDAQ
TWLV
Twelve Seas Investment C...
BOV
ADBE34M
Adobe
GATE
VETETH
VeChain Token
NASDAQ
TXG
10x Genomics
COIN
UMEXETH
UniMex
OKEX
YFVUSDT
NASDAQ
BNNRU
Banner Acquisition
BOV
RENT3R
LOCALIZA ON
BIT
F14561
Vontobel Financial Produ...
EU
FR2CIBFS6778
Credit Agricole CIB FCIA...
NYSE
SKL
EU
9365T
9365T
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados